Xellia Pharmaceuticals Is A Specialty Pharmaceutical Company Based In Copenhagendenmarkit Focuses On Critical Care Therapies And Anti Infective Treatments For Serious Infectionswith A History Dating Back To The 1950Sxellia Became An Independent Entity In 2008 And Has Been Wholly Owned By Novo Holdings A S Since 2013The Company Employs Over 1 400 People And Operates State Of The Art Manufacturing Facilities In Denmarkhungaryand China Xellia Specializes In Developingmanufacturingand Commercializing Anti Infective Productsincluding Active Pharmaceutical Ingredientsapisand Finished Dosage Formsfdfs The Company Is Known For Its Expertise In Producing Complex Anti Infectives Like Vancomycin And Tobramycin Through Advanced Techniques Such As Fermentationpurificationand Semi Synthesisxellia Serves Over 500 Pharmaceutical Companies Across More Than 80 Marketsmaintaining A Strong Presence In Both The Generic And Specialty Pharmaceutical Sectorsits Business Model Emphasizes Qualitycompetitive Pricingand Comprehensive Support For Its Customers
